Corcept Therapeutics Inc’s recent filing unveils that its Officer Maduck Sean acquired Company’s shares for reported $1.34 million on Feb 03 ’25. In the deal valued at $66.92 per share,20,000 shares were bought.
Then, Lyon Joseph Douglas bought 5,000 shares, generating $334,600 in total proceeds.
Before that, Swisher Daniel N JR sold 2,200 shares. Corcept Therapeutics Inc shares valued at $111,188 were divested by the Director at a price of $50.54 per share. As a result of the transaction, Swisher Daniel N JR now holds 0 shares, worth roughly $0.0.
Truist upgraded its Corcept Therapeutics Inc [CORT] rating to a Buy from a a Hold in a research note published on November 06, 2023; the price target was increased to $38 from $29. A number of analysts have revised their coverage, including SVB Securities’s analysts, who began to cover the stock in mid April with a ‘”a Market perform”‘ rating. Piper Sandler began covering CORT with “an Overweight” recommendation on April 04, 2023. Jefferies revised its rating on February 15, 2023. It rated CORT as “a Hold” which previously was an “a Buy”.
Price Performance Review of CORT
On Tuesday, Corcept Therapeutics Inc [NASDAQ:CORT] saw its stock jump 0.54% to $66.91. Over the last five days, the stock has gained 10.30%. Corcept Therapeutics Inc shares have risen nearly 32.78% since the year began. Nevertheless, the stocks have risen 209.34% over the past one year. While a 52-week high of $71.29 was reached on 01/31/25, a 52-week low of $20.84 was recorded on 01/13/25. SMA at 50 days reached $56.72, while 200 days put it at $41.51.
Levels Of Support And Resistance For CORT Stock
The 24-hour chart illustrates a support level at 65.96, which if violated will result in even more drops to 65.00. On the upside, there is a resistance level at 67.86. A further resistance level may holdings at 68.80. The Relative Strength Index (RSI) on the 14-day chart is 67.16, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 5.46, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 23.25%. Stochastics %K at 77.96% indicates the stock is a holding.
How much short interest is there in Corcept Therapeutics Inc?
A steep rise in short interest was recorded in Corcept Therapeutics Inc stocks on 2025-01-15, growing by 0.54 million shares to a total of 16.26 million shares. Yahoo Finance data shows the prior-month short interest on 2024-12-13 was 15.72 million shares. There was a rise of 3.34%, which implies that there is a positive sentiment for the stock.
